Early immune adaptation in HIV-1 revealed by population-level approaches

Retrovirology

Volumn 11, Issue 1, 2014, Pages

  Martin, Eric ^a,b   Carlson, Jonathan M ^c   Le, Anh Q ^a   Chopera, Denis R ^a,d   McGovern, Rachel ^b   Rahman, Manal A ^a   Ng, Carmond ^b   Jessen, Heiko ^e   Kelleher, Anthony D ^f   Markowitz, Martin ^g   Allen, Todd M ^h   Milloy, M J ^b,i   Carrington, Mary ^h,j   Wainberg, Mark A ^k   Brumme, Zabrina L ^a,b  

^a SIMON FRASER UNIVERSITY   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c MICROSOFT RESEARCH   (United States)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e Jessen Praxis   (Germany)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g ROCKEFELLER UNIVERSITY   (United States)

^h HARVARD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^k MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Acute early infection; Adaptation; CD8+ cytotoxic T lymphocytes (CTL); Evolution; HLA associated polymorphism; Human immunodeficiency virus type 1 (HIV 1); Human leukocyte antigen (HLA) class I; Immune escape; Population level analysis; Statistical association with phylogenetic correction

Indexed keywords

HLA A1 ANTIGEN; GAG PROTEIN; HLA ANTIGEN CLASS 1; NEF PROTEIN;

ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; POPULATION RISK; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS IMMUNITY; ADAPTATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; IMMUNOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADAPTATION, PHYSIOLOGICAL; CROSS-SECTIONAL STUDIES; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84908086079     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-014-0064-1     Document Type: Article

References (56)

1. Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 2004, 4:630-640. 10.1038/nri1417, 15286729.
2. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJ. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004, 10:282-289. 10.1038/nm992, 14770175.
3. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, Berlin AM, Malboeuf CM, Ryan EM, Gnerre S, Zody MC, Erlich RL, Green LM, Berical A, Wang Y, Casali M, Streeck H, Bloom AK, Dudek T, Tully D, Newman R, Axten KL, Gladden AD, Battis L, Kemper M, Zeng Q, Shea TP, Gujja S, Zedlack C, Gasser O, et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 2012, 8:e1002529. 10.1371/journal.ppat.1002529, 22412369.
4. Crawford H, Prado JG, Leslie A, Hue S, Honeyborne I, Reddy S, van der Stok M, Mncube Z, Brander C, Rousseau C, Mullins JI, Kaslow R, Goepfert P, Allen S, Hunter E, Mulenga J, Kiepiela P, Walker BD, Goulder PJ. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol 2007, 81:8346-8351. 10.1128/JVI.00465-07, 17507468.
5. Fryer HR, Frater J, Duda A, Roberts MG, Phillips RE, McLean AR. Modelling the evolution and spread of HIV immune escape mutants. PLoS Pathog 2010, 6:e1001196. 10.1371/journal.ppat.1001196, 21124991.
6. Leslie A, Kavanagh D, Honeyborne I, Pfafferott K, Edwards C, Pillay T, Hilton L, Thobakgale C, Ramduth D, Draenert R, Le Gall S, Luzzi G, Edwards A, Brander C, Sewell AK, Moore S, Mullins J, Moore C, Mallal S, Bhardwaj N, Yusim K, Phillips R, Klenerman P, Korber B, Kiepiela P, Walker B, Goulder P. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med 2005, 201:891-902. 10.1084/jem.20041455, 15781581.
7. Schneidewind A, Brumme ZL, Brumme CJ, Power KA, Reyor LL, O'Sullivan K, Gladden A, Hempel U, Kuntzen T, Wang YE, Oniangue-Ndza C, Jessen H, Markowitz M, Rosenberg ES, Sekaly RP, Kelleher AD, Walker BD, Allen TM. Transmission and long-term stability of compensated CD8 escape mutations. J Virol 2009, 83:3993-3997. 10.1128/JVI.01108-08, 19091871.
8. Cornelissen M, Hoogland FM, Back NK, Jurriaans S, Zorgdrager F, Bakker M, Brinkman K, Prins M, van der Kuyl AC. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands. AIDS 2009, 23:1495-1500. 10.1097/QAD.0b013e32832d9267, 19487902.
9. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002, 296:1439-1443. 10.1126/science.1069660, 12029127.
10. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Swenson LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM, Frahm N, Brander C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS ONE 2009, 4:e6687. 10.1371/journal.pone.0006687, 19690614.
11. Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman MA, Le AQ, Chui CK, Cotton LA, Knapp DJ, Riddler SA, Haubrich R, Nelson G, Pfeifer N, Deziel CE, Heckerman D, Apps R, Carrington M, Mallal S, Harrigan PR, John M, Brumme ZL. Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol 2012, 86:13202-13216. 10.1128/JVI.01998-12, 23055555.
12. Carlson JM, Listgarten J, Pfeifer N, Tan V, Kadie C, Walker BD, Ndung'u T, Shapiro R, Frater J, Brumme ZL, Goulder PJ, Heckerman D. Widespread Impact of HLA Restriction on Immune Control and Escape Pathways of HIV-1. J Virol 2012, 86:5230-5243. 10.1128/JVI.06728-11, 22379086.
13. Brumme ZL, Brumme CJ, Carlson J, Streeck H, John M, Eichbaum Q, Block BL, Baker B, Kadie C, Markowitz M, Jessen H, Kelleher AD, Rosenberg E, Kaldor J, Yuki Y, Carrington M, Allen TM, Mallal S, Altfeld M, Heckerman D, Walker BD. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 2008, 82:9216-9227. 10.1128/JVI.01041-08, 18614631.
14. Duda A, Lee-Turner L, Fox J, Robinson N, Dustan S, Kaye S, Fryer H, Carrington M, McClure M, McLean AR, Fidler S, Weber J, Phillips RE, Frater AJ. HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol 2009, 83:1228-1239. 10.1128/JVI.01545-08, 19019964.
15. Li B, Gladden AD, Altfeld M, Kaldor JM, Cooper DA, Kelleher AD, Allen TM. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol 2007, 81:193-201. 10.1128/JVI.01231-06, 17065207.
16. Yager N, Robinson N, Brown H, Flanagan P, Frater J, Fidler S, Weber J, Phillips R. Longitudinal analysis of an HLA-B * 51-restricted epitope in integrase reveals immune escape in early HIV-1 infection. AIDS 2013, 27:313-323. 10.1097/QAD.0b013e32835b8cf5, 23095315.
17. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, Han CS, Gleasner CD, Green L, Lo CC, Nag A, Wallstrom TC, Wang S, McMichael AJ, Haynes BF, Hahn BH, Perelson AS, Borrow P, Shaw GM, Bhattacharya T, Korber BT. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS ONE 2010, 5:e12303. 10.1371/journal.pone.0012303, 20808830.
18. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, Weinhold KJ, Moore S, Letvin N, Haynes BF, Cohen MS, Hraber P, Bhattacharya T, Borrow P, Perelson AS, Hahn BH, Shaw GM, Korber BT, McMichael AJ. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009, 206:1253-1272. 10.1084/jem.20090365, 19487423.
19. Liu MK, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M, Treurnicht F, Hraber P, Riou C, Gray C, Ferrari G, Tanner R, Ping LH, Anderson JA, Swanstrom R, Cohen M, Karim SS, Haynes B, Borrow P, Perelson AS, Shaw GM, Hahn BH, Williamson C, Korber BT, Gao F, Self S, et al. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest 2013, 123:380-393. 23221345.
20. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Bethesda (MD): Department of Health and Human Services (DHHS); 2013.
21. Fryer HR, Frater J, Duda A, Palmer D, Phillips RE, McLean AR. Cytotoxic T-lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly. J Virol 2012, 86:8568-8580. 10.1128/JVI.07020-11, 22674992.
22. Huang KH, Goedhals D, Carlson JM, Brockman MA, Mishra S, Brumme ZL, Hickling S, Tang CS, Miura T, Seebregts C, Heckerman D, Ndung'u T, Walker B, Klenerman P, Steyn D, Goulder P, Phillips R, van Vuuren C, Frater J. Progression to AIDS in South Africa Is Associated with both Reverting and Compensatory Viral Mutations. PLoS One 2011, 6:e19018. 10.1371/journal.pone.0019018, 21544209.
23. Brockman MA, Chopera DR, Olvera A, Brumme CJ, Sela J, Markle TJ, Martin E, Carlson JM, Le AQ, McGovern R, Cheung PK, Kelleher AD, Jessen H, Markowitz M, Rosenberg E, Frahm N, Sanchez J, Mallal S, John M, Harrigan PR, Heckerman D, Brander C, Walker BD, Brumme ZL. Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. J Virol 2012, 86:6913-6923. 10.1128/JVI.07133-11, 22496233.
24. Poon AF, McGovern RA, Mo T, Knapp DJ, Brenner B, Routy JP, Wainberg MA, Harrigan PR. Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data. AIDS 2011, 25:2019-2026. 10.1097/QAD.0b013e32834b643c, 21832936.
25. Cotton LA, Kuang XT, Le AQ, Carlson JM, Chan B, Chopera DR, Brumme CJ, Markle TJ, Martin E, Shahid A, Anmole G, Mwimanzi P, Nassab P, Penney KA, Rahman MA, Milloy MJ, Schechter MT, Markowitz M, Carrington M, Walker BD, Wagner T, Buchbinder S, Fuchs J, Koblin B, Mayer KH, Harrigan PR, Brockman MA, Poon AF, Brumme ZL. Genotypic and Functional Impact of HIV-1 Adaptation to Its Host Population during the North American Epidemic. PLoS Genet 2014, 10:e1004295. 10.1371/journal.pgen.1004295, 24762668.
26. Carlson JM, Brumme ZL, Rousseau CM, Brumme CJ, Matthews P, Kadie C, Mullins JI, Walker BD, Harrigan PR, Goulder PJ, Heckerman D. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput Biol 2008, 4:e1000225. 10.1371/journal.pcbi.1000225, 19023406.
27. Chikata T, Carlson JM, Tamura Y, Borghan MA, Naruto T, Hashimoto M, Murakoshi H, Le AQ, Mallal S, John M, Gatanaga H, Oka S, Brumme ZL, Takiguchi M. Host-specific adaptation of HIV-1 subtype B in the Japanese population. J Virol 2014, 88:4764-4775. 10.1128/JVI.00147-14, 24522911.
28. Turnbull EL, Baalwa J, Conrod KE, Wang S, Wei X, Wong M, Turner J, Pellegrino P, Williams I, Shaw GM, Borrow P. Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection. Retrovirology 2011, 8:41. 10.1186/1742-4690-8-41, 21635736.
29. Brackenridge S, Evans EJ, Toebes M, Goonetilleke N, Liu MK, di Gleria K, Schumacher TN, Davis SJ, McMichael AJ, Gillespie GM. An early HIV mutation within an HLA-B * 57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J Virol 2011, 85:5415-5422. 10.1128/JVI.00238-11, 21430058.
30. Tomiyama H, Sakaguchi T, Miwa K, Oka S, Iwamoto A, Kaneko Y, Takiguchi M. Identification of multiple HIV-1 CTL epitopes presented by HLA-B * 5101 molecules. Hum Immunol 1999, 60:177-186. 10.1016/S0198-8859(98)00113-X, 10321954.
31. Altfeld M, Kalife ET, Qi Y, Streeck H, Lichterfeld M, Johnston MN, Burgett N, Swartz ME, Yang A, Alter G, Yu XG, Meier A, Rockstroh JK, Allen TM, Jessen H, Rosenberg ES, Carrington M, Walker BD. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med 2006, 3:e403. 10.1371/journal.pmed.0030403, 17076553.
32. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, Rowland-Jones S. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997, 3:212-217. 10.1038/nm0297-212, 9018241.
33. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, Rinaldo CR, Craggs SL, Allgaier RL, Power KA, Kuntzen T, Tung CS, LaBute MX, Mueller SM, Harrer T, McMichael AJ, Goulder PJ, Aiken C, Brander C, Kelleher AD, Allen TM. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 2007, 81:12382-12393. 10.1128/JVI.01543-07, 17804494.
34. Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, Wong K, Stoddard JN, Raugi D, Sorensen S, Genowati I, Birditt B, McKay A, Diem K, Maust BS, Deng W, Collier AC, Stekler JD, McElrath MJ, Mullins JI. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol 2011, 85:7523-7534. 10.1128/JVI.02697-10, 21593162.
35. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, Carlson J, Kadie C, Bhattacharya T, Chui C, Szinger J, Mo T, Hogg RS, Montaner JS, Frahm N, Brander C, Walker BD, Harrigan PR. Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1. PLoS Pathog 2007, 3:e94. 10.1371/journal.ppat.0030094, 17616974.
36. O'Brien SJ, Gao X, Carrington M. HLA and AIDS: a cautionary tale. Trends Mol Med 2001, 7:379-381. 10.1016/S1471-4914(01)02131-1, 11530315.
37. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong K, McLaughlin S, McSweyn MD, Diem K, Stevens CE, Maenza J, He H, Nickle DC, Shriner D, Holte SE, Collier AC, Corey L, McElrath MJ, Mullins JI. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 2006, 80:9519-9529. 10.1128/JVI.00575-06, 16973556.
38. Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, Addo MM, Brumme C, Routy JP, Little S, Jessen HK, Kelleher AD, Hecht FM, Sekaly RP, Rosenberg ES, Walker BD, Carrington M, Altfeld M. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol 2009, 83:7641-7648. 10.1128/JVI.00182-09, 19458000.
39. Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, Prentice HA, Yue L, Vishwanathan SA, Kilembe W, Goepfert P, Price MA, Gilmour J, Mulenga J, Farmer P, Derdeyn CA, Tang J, Heckerman D, Kaslow RA, Allen SA, Hunter E. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog 2012, 8:e1003041. 10.1371/journal.ppat.1003041, 23209412.
40. Song H, Pavlicek JW, Cai F, Bhattacharya T, Li H, Iyer SS, Bar KJ, Decker JM, Goonetilleke N, Liu MK, Berg A, Hora B, Drinker MS, Eudailey J, Pickeral J, Moody MA, Ferrari G, McMichael A, Perelson AS, Shaw GM, Hahn BH, Haynes BF, Gao F. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome. Retrovirology 2012, 9:89. 10.1186/1742-4690-9-89, 23110705.
41. Borghans JA, Molgaard A, de Boer RJ, Kesmir C. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS ONE 2007, 2:e920. 10.1371/journal.pone.0000920, 17878955.
42. Streeck H, Lichterfeld M, Alter G, Meier A, Teigen N, Yassine-Diab B, Sidhu HK, Little S, Kelleher A, Routy JP, Rosenberg ES, Sekaly RP, Walker BD, Altfeld M. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol 2007, 81:7725-7731. 10.1128/JVI.00708-07, 17494064.
43. Brennan CA, Ibarrondo FJ, Sugar CA, Hausner MA, Shih R, Ng HL, Detels R, Margolick JB, Rinaldo CR, Phair J, Jacobson LP, Yang OO, Jamieson BD. Early HLA-B * 57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression. J Virol 2012, 86:10505-10516. 10.1128/JVI.00102-12, 22811521.
44. Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, Desouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol 2007, 81:12608-12618. 10.1128/JVI.01369-07, 17728232.
45. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, Goulder P. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 2006, 80:3617-3623. 10.1128/JVI.80.7.3617-3623.2006, 16537629.
46. Crawford H, Lumm W, Leslie A, Schaefer M, Boeras D, Prado JG, Tang J, Farmer P, Ndung'u T, Lakhi S, Gilmour J, Goepfert P, Walker BD, Kaslow R, Mulenga J, Allen S, Goulder PJ, Hunter E. Evolution of HLA-B * 5703 HIV-1 escape mutations in HLA-B* 5703-positive individuals and their transmission recipients. J Exp Med 2009, 206:909-921. 19307327.
47. Feeney ME, Tang Y, Roosevelt KA, Leslie AJ, McIntosh K, Karthas N, Walker BD, Goulder PJ. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol 2004, 78:8927-8930. 10.1128/JVI.78.16.8927-8930.2004, 15280502.
48. Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, Carrington M. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005, 11:1290-1292. 10.1038/nm1333, 16288280.
49. Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, Conlon C, Workman C, Shaunak S, Olson K, Goulder P, Brander C, Ogg G, Sullivan JS, Dyer W, Jones I, McMichael AJ, Rowland-Jones S, Phillips RE. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001, 193:375-386. 10.1084/jem.193.3.375, 11157057.
50. Montaner JS. Treatment as prevention: toward an AIDS-free generation. Top Antivir Med 2013, 21:110-114. 23981598.
51. Woods CK, Brumme CJ, Liu TF, Chui CK, Chu AL, Wynhoven B, Hall TA, Trevino C, Shafer RW, Harrigan PR. Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. J Clin Microbiol 2012, 50:1936-1942. 10.1128/JCM.06689-11, 22403431.
52. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010, 59:307-321. 10.1093/sysbio/syq010, 20525638.
53. Fourment M, Gibbs MJ. PATRISTIC: a program for calculating patristic distances and graphically comparing the components of genetic change. BMC Evol Biol 2006, 6:1. 10.1186/1471-2148-6-1, 16388682.
54. Cotton LA, Rahman MA, Ng C, Le AQ, Milloy MJ, Mo T, Brumme ZL. HLA class I sequence-based typing using DNA recovered from frozen plasma. J Immunol Methods 2012, 382:40-47. 10.1016/j.jim.2012.05.003, 22584155.
55. Listgarten J, Brumme Z, Kadie C, Xiaojiang G, Walker B, Carrington M, Goulder P, Heckerman D. Statistical resolution of ambiguous HLA typing data. PLoS Comput Biol 2008, 4:e1000016. 10.1371/journal.pcbi.1000016, 18392148.
56. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003, 100:9440-9445. 10.1073/pnas.1530509100, 12883005.